Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Blockage of FOXP3 transcription factor dimerization and FOXP3/AML1 interaction inhibits T regulatory cell activity: sequence optimization of a peptide inhibitor

13 May 2017

Abstract excerpt

// Teresa Lozano 1 , Marta Gorraiz 1 , Aritz Lasarte-Cía 1 , Marta Ruiz 1 , Obdulia Rabal 2 , Julen Oyarzabal 2 , Sandra Hervás-Stubbs 1 , Diana Llopiz 1 , Pablo Sarobe 1 , Jesús Prieto 1 , Noelia Casares 1 and Juan José Lasarte 1 1 Immunology and Immunotherapy Program, University of Navarra, 31008, IDISNA, Pamplona, Spain 2 Small Molecule Discovery Platform, Molecular Therapeutics Program, Center for Applied...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to Immune Cell Function and Interaction
Share to T-cell and B-cell Immunology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29069740
DOI: 10.18632/oncotarget.17845

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Blockage of FOXP3 transcription factor dimerization and FOXP3/AML1 interaction inhibits T regulatory cell activity: sequence optimization of a peptide inhibitorPMID 29069740Read ↗

Molecular and biological role of the FOXP3 N-terminal domain in immune regulation by T regulatory/suppressor cells.Semantic proximity Read ↗

PRMT5 Associates With the FOXP3 Homomer and When Disabled Enhances Targeted p185erbB2/neu Tumor ImmunotherapySemantic proximity Read ↗

FOXP3+ Treg as a therapeutic target for promoting anti-tumor immunity.Semantic proximity Read ↗

Two lysines in the forkhead domain of foxp3 are key to T regulatory cell function.Semantic proximity Read ↗

Targeting Foxp3 Tumor Intrinsic Effects Using Adenoviral Vectors in Experimental Breast CancerSemantic proximity Read ↗

The splicing isoform Foxp3Δ2 releases the autoinhibitory conformation and differentially regulates tTregs and pTregs homeostasisSemantic proximity Read ↗

Ikzf1 association with Foxp3 for Foxp3-dependent gene repression in Treg cells: induction of autoimmunity and tumor immunity by disrupting the associationSemantic proximity Read ↗

Structural and biological features of FOXP3 dimerization relevant to regulatory T cell function.Semantic proximity Read ↗

The Role of FOXP3 in Human Cancers.Semantic proximity Read ↗

Post-Translational Regulations of Foxp3 in Treg Cells and Their Therapeutic Applications.Semantic proximity Read ↗

Lysosome-dependent p300/FOXP3 degradation and limits Treg cell functions and enhances targeted therapy against cancers.Semantic proximity Read ↗

Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.